A research team has succeeded in synthesizing simple, environmentally sensitive cells complete with artificial organelles. For the first time, the researchers have also been able to emulate natural ...

The global ageing population and growing awareness of the benefits of orthobiologic therapy are driving the size of the global orthobiologics market.

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Paris-based biotechnology company Cellectis (NASDAQ: CLLS) has announced the first patient in the U.S. to receive a dose of its UCART22 allogeneic CAR T-cell therapy product candidate that was ...